Results 61 to 70 of about 10,636 (185)

Neuroleptic malignant syndrome following catatonia: Vigilance is the price of antipsychotic prescription

SAGE Open Medical Case Reports, 2017
Objectives: To describe a case of neuroleptic malignant syndrome following antipsychotic treatment of catatonia, highlighting the potentially serious complications of this rare adverse drug reaction.
Thomas J Reilly, Sean Cross, David M Taylor, Richard Haslam, Sophie C Tomlin, Benjamin Gaastra   +5 more
doaj   +1 more source

Second generation antipsychotics causing neuroleptic malignant syndrome

Sri Lanka Journal of Psychiatry, 2016
Neuroleptic malignant syndrome (NMS) is a rare yet potentially lethal medical emergency encountered by psychiatrists. NMS is commonly associated with potent first generation antipsychotics, especially haloperidol and fluphenazine. However, there are many
C. Suraweera, R. Hanwella, V. De Silva
doaj   +1 more source

Diagnosis in the Neuroleptic Malignant Syndrome [PDF]

, 2011
Neuroleptic malignant syndrome (NMS) is an uncommon, potentially lethal complication of treatment with antipsychotic medication. First described in American journals by Delay and Deniker in 1968 (1), this syndrome has been reported for many years in the ...
Dallman, MD, CPT, MC, James H.
core   +1 more source

Delayed-Onset Malignant Hyperthermia in Association with Rocuronium Use [PDF]

, 2012
Purpose Two cases of malignant hyperthermia suspected to be related to the use of a nondepolarizing neuromuscular blocker are reported. Summary A pharmacogenetic disorder that may occur in as many as 1 in 3000 anesthesia procedures, malignant ...
Beggs, Ashton E., McCann, Jennifer Quinn, Powers, Jan M.   +2 more
core   +2 more sources

Association Between Abnormal DNA Methylation and Altered Transcriptome in Muscle Five Years After Critical Illness

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Critically ill patients requiring intensive care unit (ICU) admission suffer from muscle weakness that persists for years. Recently, altered RNA expression was documented in muscle of former ICU patients 5 years after critical illness that suggested disrupted mitochondrial function, disturbed lipid metabolism and fibrosis, of which ...
Ceren Uzun Ayar, Fabian Güiza, Inge Derese, Greet Van den Berghe, Ilse Vanhorebeek   +4 more
wiley   +1 more source

Neuroleptic malignant syndrome: a fatal case with unusual features

Sri Lanka Journal of Psychiatry, 2014
Neuroleptic malignant syndrome is a rare, but potentially life threatening, idiosyncratic reaction primarily related to use of neuroleptic medications.
U. M. Wariyapperuma, C. I.V. Jayasundera
doaj   +1 more source

Lorazepam provocation test in purported schizophrenia with lack of treatment response [PDF]

, 2014
Some patients with severe mental disorders are refractory to psychotherapeutic or psychopharmacological interventions. We present a patient who at the age of 19 developed several schizophrenia - suspect symptoms.
Berg, John E.
core   +3 more sources

Neuro‐Immune Crosstalk: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets

MedComm, Volume 7, Issue 2, February 2026.
Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo, Hui Liu, Yu‐Jing Song, Jian‐Hua Wang, Danfeng Liu, Zhi‐Wei Zheng, Jia‐Jun Li, Boya Li, An Song, Wei He, Lei‐Lei Yang, Shuo Wang   +11 more
wiley   +1 more source

Neuroleptic malignant syndrome in an adolescent with the GNAO1 mutation movement disorder phenotype: a challenging diagnosis

Portuguese Journal of Pediatrics
Introduction: Neuroleptic malignant syndrome (NMS) is a rare and life-threatening condition resulting from exposure to dopamine-blocking agents. GNAO1 mutations are a neurodevelopmental disorder associated with a hyperkinetic movement disorder, usually ...
Mónica Santos, Tiago Proença dos Santos, Sofia Almeida, Miguel Coelho, António Levy   +4 more
doaj   +1 more source

Diagnostic, Treatment, and System Challenges in the Management of Recurrent Neuroleptic Malignant Syndrome on a General Medical Service

Case Reports in Psychiatry, 2018
Neuroleptic malignant syndrome (NMS), an iatrogenic form of malignant catatonia, carries high morbidity and mortality rates especially in the context of delayed recognition and standard intervention protocol of lorazepam trial.
Karan Verma, Vivek Jayadeva, Raymond Serrano, Karthik Sivashanker   +3 more
doaj   +1 more source